ABL (gene)

ABL1
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 1AB2, 1AWO, 1BBZ, 1JU5, 1OPL, 1ZZP, 2ABL, 2E2B, 2FO0, 2G1T, 2G2F, 2G2H, 2G2I, 2GQG, 2HIW, 2HYY, 2HZ0, 2HZ4, 2HZI, 2V7A, 3CS9, 3EG0, 3EG1, 3EG2, 3EG3, 3EGU, 3K2M, 3QRI, 3QRJ, 3QRK, 3T04, 3UE4, 3UYO, 3PYY, 4J9B, 4J9C, 4J9D, 4J9E, 4J9F, 4J9G, 4J9H, 4J9I, 4JJB, 4JJC, 4JJD, 4TWP, 4WA9, 4XEY, 4YC8, 5DC9, 5DC4, 5DC0, 2O88, 5HU9
Identifiers
Aliases	ABL1 , ABL proto-oncogene 1, non-receptor tyrosine kinase, ABL, JTK7, bcr/abl, c-ABL, c-p150, v-abl, CHDSKM, BCR-ABL, Genes, abl
External IDs	OMIM: 189980; MGI: 87859; HomoloGene: 3783; GeneCards: ABL1; OMA:ABL1 - orthologs
EC number	2.7.10.2
Gene location (Human) Chr. Chromosome 9 (human) [1] Band 9q34.12 Start 130,713,016 bp [1] End 130,887,675 bp [1]
Gene location (Mouse) Chr. Chromosome 2 (mouse) [2] Band 2 21.86 cM|2 B Start 31,578,388 bp [2] End 31,694,239 bp [2]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in frontal pole paraflocculus of cerebellum middle frontal gyrus muscle layer of sigmoid colon gastric mucosa stromal cell of endometrium left uterine tube ventricular zone body of uterus ganglionic eminence Top expressed in external carotid artery internal carotid artery Gonadal ridge genital tubercle tail of embryo vas deferens condyle endocardial cushion vestibular membrane of cochlear duct ventricular zone More reference expression data BioGPS More reference expression data
Gene ontology Molecular function actin monomer binding protein domain specific binding SH3 domain binding kinase activity protein C-terminus binding signaling receptor binding ATP binding protein kinase activity nicotinate-nucleotide adenylyltransferase activity non-membrane spanning protein tyrosine kinase activity metal ion binding proline-rich region binding magnesium ion binding transferase activity actin filament binding protein binding syntaxin binding protein kinase C binding DNA binding nucleotide binding manganese ion binding mitogen-activated protein kinase binding protein tyrosine kinase activity four-way junction DNA binding bubble DNA binding phosphotyrosine residue binding transcription coactivator activity neuropilin binding SH2 domain binding ephrin receptor binding supercoiled DNA binding sequence-specific double-stranded DNA binding Cellular component cytoplasm cytosol nuclear membrane membrane extrinsic component of cytoplasmic side of plasma membrane mitochondrion actin cytoskeleton perinuclear region of cytoplasm cytoskeleton nucleus nucleolus nucleoplasm cell leading edge nuclear body dendrite protein-containing complex neuronal cell body postsynapse Biological process positive regulation of protein phosphorylation B-1 B cell homeostasis regulation of axon extension neuromuscular process controlling balance positive regulation of muscle cell differentiation cellular response to DNA damage stimulus protein phosphorylation regulation of cell adhesion regulation of microtubule polymerization DNA damage induced protein phosphorylation intrinsic apoptotic signaling pathway in response to DNA damage positive regulation of ERK1 and ERK2 cascade substrate adhesion-dependent cell spreading platelet-derived growth factor receptor-beta signaling pathway positive regulation of actin filament binding B cell receptor signaling pathway apoptotic process negative regulation of endothelial cell apoptotic process cerebellum morphogenesis regulation of actin cytoskeleton reorganization regulation of transcription, DNA-templated epidermal growth factor receptor signaling pathway Fc-gamma receptor signaling pathway involved in phagocytosis establishment of protein localization thymus development negative regulation of phospholipase C activity positive regulation of mitotic cell cycle actin filament branching spleen development response to oxidative stress phagocytosis positive regulation of peptidyl-tyrosine phosphorylation regulation of response to DNA damage stimulus mitochondrial depolarization positive regulation of Wnt signaling pathway, planar cell polarity pathway platelet-derived growth factor receptor signaling pathway regulation of endocytosis activation of protein kinase C activity regulation of actin cytoskeleton organization phosphorylation signal transduction in response to DNA damage positive regulation of oxidoreductase activity positive regulation of release of sequestered calcium ion into cytosol negative regulation of I-kappaB kinase/NF-kappaB signaling regulation of cell motility positive regulation of microtubule binding cell adhesion regulation of autophagy peptidyl-tyrosine autophosphorylation alpha-beta T cell differentiation regulation of cellular senescence negative regulation of protein serine/threonine kinase activity actin cytoskeleton organization negative regulation of cellular senescence positive regulation of osteoblast proliferation mitotic cell cycle activated T cell proliferation endocytosis negative regulation of cell-cell adhesion B cell proliferation involved in immune response cellular response to dopamine positive regulation of cytosolic calcium ion concentration positive regulation of neuron death regulation of cell cycle negative regulation of BMP signaling pathway autophagy B cell proliferation negative regulation of ubiquitin-protein transferase activity microspike assembly positive regulation of apoptotic process regulation of extracellular matrix organization positive regulation of I-kappaB kinase/NF-kappaB signaling negative regulation of ERK1 and ERK2 cascade transitional one stage B cell differentiation DNA mismatch repair Bergmann glial cell differentiation peptidyl-tyrosine phosphorylation collateral sprouting cellular response to lipopolysaccharide negative regulation of mitotic cell cycle cellular response to hydrogen peroxide DNA repair innate immune response neural tube closure post-embryonic development neuron differentiation cellular response to oxidative stress regulation of cell population proliferation protein autophosphorylation neuroepithelial cell differentiation integrin-mediated signaling pathway positive regulation of endothelial cell migration cell differentiation regulation of Cdc42 protein signal transduction neuropilin signaling pathway endothelial cell migration regulation of T cell differentiation positive regulation of transcription by RNA polymerase II T cell receptor signaling pathway positive regulation of stress fiber assembly positive regulation of focal adhesion assembly DNA conformation change positive regulation of cell migration involved in sprouting angiogenesis positive regulation of substrate adhesion-dependent cell spreading negative regulation of long-term synaptic potentiation regulation of hematopoietic stem cell differentiation regulation of modification of synaptic structure positive regulation of blood vessel branching positive regulation of actin cytoskeleton reorganization Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 25 11350 Ensembl ENSG00000097007 ENSMUSG00000026842 UniProt P00519 P00520 RefSeq (mRNA) NM_007313 NM_005157 NM_001112703 NM_009594 NM_001283045 NM_001283046 NM_001283047 RefSeq (protein) NP_005148 NP_009297 NP_001106174 NP_001269974 NP_001269975 NP_001269976 NP_033724 Location (UCSC) Chr 9: 130.71 – 130.89 Mb Chr 2: 31.58 – 31.69 Mb PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Tyrosine-protein kinase ABL1 also known as ABL1 is a protein that, in humans, is encoded by the ABL1 gene (previous symbol ABL) located on chromosome 9. ^[5] c-Abl is sometimes used to refer to the version of the gene found within the mammalian genome, while v-Abl refers to the viral gene, which was initially isolated from the Abelson murine leukemia virus. ^[6]

Function

The ABL1 proto-oncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response such as DNA repair. ^{[7] [8] [9] [10]} Activity of ABL1 protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR and ABL1 genes, leading to a fusion gene present in many cases of chronic myelogenous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or a 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2–11. ^[11]

Clinical significance

ABL1 kinase domain (blue) in complex with the second-generation Bcr-Abl tyrosine-kinase inhibitor nilotinib (red)

Mutations in the ABL1 gene are associated with chronic myelogenous leukemia (CML). In CML, the gene is activated by being translocated within the BCR (breakpoint cluster region) gene on chromosome 22. This new fusion gene, BCR-ABL, encodes an unregulated, cytoplasm-targeted tyrosine kinase that allows the cells to proliferate without being regulated by cytokines. This, in turn, allows the cell to become cancerous.

This gene is a partner in a fusion gene with the BCR gene in the Philadelphia chromosome, a characteristic abnormality in chronic myelogenous leukemia (CML) and rarely in some other leukemia forms. The BCR-ABL transcript encodes a tyrosine kinase, which activates mediators of the cell cycle regulation system, leading to a clonal myeloproliferative disorder. The BCR-ABL protein can be inhibited by various small molecules. One such inhibitor is imatinib mesylate, which occupies the tyrosine kinase domain and inhibits BCR-ABL's influence on the cell cycle. Second generation BCR-ABL tyrosine-kinase inhibitors are also under development to inhibit BCR-ABL mutants resistant to imatinib. ^[12]

Interactions

ABL gene has been shown to interact with:

• ABI1, ^{[13] [14] [15]}
• ABI2, ^{[16] [17]}
• ABL2, ^[16]
• ATM, ^{[18] [19] [20]}
• BCAR1, ^{[21] [22]}
• BCR, ^{[23] [24] [25]}
• BRCA1, ^[26]
• CAT, ^[27]
• CBL, ^{[28] [29]}
• CRKL, ^{[30] [31] [32]}
• DOK1, ^{[33] [34]}
• EPHB2, ^[35]
• GPX1, ^[36]
• GRB10, ^{[37] [38]}
• MTOR, ^[39]
• GRB2, ^{[30] [40]}
• MDM2, ^[41]
• NCK1, ^{[28] [30]}
• NEDD9, ^{[42] [43]}
• NTRK1, ^{[44] [45]}
• P73, ^{[46] [47]}
• PAG1, ^[48]
• PAK2, ^[49]
• PSTPIP1, ^[50]
• RAD9A, ^[51]
• RAD51, ^[18]
• RB1, ^{[52] [53]}
• RFX1, ^[54]
• RYBP, ^[55]
• SHC1, ^{[23] [56]}
• SORBS2, ^{[29] [57]}
• SPTA1, ^[58]
• SPTAN1, ^[58]
• TERF1, ^[20]
• VAV1, ^[59] and
• YTHDC1. ^[60]

Regulation

There is some evidence that the expression of Abl is regulated by the microRNA miR-203. ^[61]

See also

• BCR gene

References

1. GRCh38: Ensembl release 89: ENSG00000097007 – Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000026842 – Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM, Calabretta B (August 1991). "Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides". Science. 253 (5019): 562–5. Bibcode:1991Sci...253..562S. doi:10.1126/science.1857987. PMID   1857987.
6. Abelson HT, Rabstein LS (August 1970). "Lymphosarcoma: virus-induced thymic-independent disease in mice". Cancer Research. 30 (8): 2213–22. PMID   4318922.
7. Takizawa Y, Kinebuchi T, Kagawa W, Yokoyama S, Shibata T, Kurumizaka H (September 2004). "Mutational analyses of the human Rad51-Tyr315 residue, a site for phosphorylation in leukaemia cells". Genes to Cells. 9 (9): 781–90. doi:10.1111/j.1365-2443.2004.00772.x. PMID   15330855. S2CID   22916981.
8. Salles D, Mencalha AL, Ireno IC, Wiesmüller L, Abdelhay E (January 2011). "BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP". Carcinogenesis. 32 (1): 27–34. doi: 10.1093/carcin/bgq216 . PMID   20974687.
9. Siddiqui A, Tumiati M, Joko A, Sandholm J, Roering P, Aakko S, et al. (2021). "Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition". Frontiers in Oncology. 11: 3666. doi: 10.3389/fonc.2021.733700 . PMC   8488401 . PMID   34616682.
10. "UniProtKB - P00519 (ABL1_HUMAN)". Uniprot. Retrieved 18 May 2020.
11. "Entrez Gene: ABL1 v-abl Abelson murine leukemia viral oncogene homolog 1".
12. Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers CL (July 2004). "Overriding imatinib resistance with a novel ABL kinase inhibitor". Science. 305 (5682): 399–401. Bibcode:2004Sci...305..399S. doi:10.1126/science.1099480. PMID   15256671. S2CID   34972913.
13. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H, Shishido T (June 2003). "Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase". J. Biol. Chem. 278 (24): 21685–92. doi: 10.1074/jbc.M301447200 . PMID   12672821.
14. Biesova Z, Piccoli C, Wong WT (January 1997). "Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth". Oncogene. 14 (2): 233–41. doi:10.1038/sj.onc.1200822. PMID   9010225. S2CID   22964580.
15. Yamamoto A, Suzuki T, Sakaki Y (June 2001). "Isolation of hNap1BP which interacts with human Nap1 (NCKAP1) whose expression is down-regulated in Alzheimer's disease". Gene. 271 (2): 159–69. doi:10.1016/S0378-1119(01)00521-2. PMID   11418237.
16. Cao C, Leng Y, Li C, Kufe D (April 2003). "Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response". J. Biol. Chem. 278 (15): 12961–7. doi: 10.1074/jbc.M300058200 . PMID   12569093.
17. Dai Z, Pendergast AM (November 1995). "Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity". Genes Dev. 9 (21): 2569–82. doi: 10.1101/gad.9.21.2569 . PMID   7590236.
18. Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, Park MS, Sung P, Lee EY (April 1999). "Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl". J. Biol. Chem. 274 (18): 12748–52. doi: 10.1074/jbc.274.18.12748 . PMID   10212258.
19. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin MF (May 1997). "Interaction between ATM protein and c-Abl in response to DNA damage". Nature. 387 (6632): 520–3. Bibcode:1997Natur.387R.520S. doi:10.1038/387520a0. PMID   9168117. S2CID   4334242.
20. Kishi S, Zhou XZ, Ziv Y, Khoo C, Hill DE, Shiloh Y, Lu KP (August 2001). "Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks". J. Biol. Chem. 276 (31): 29282–91. doi: 10.1074/jbc.M011534200 . PMID   11375976.
21. Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD (October 1996). "p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene". J. Biol. Chem. 271 (41): 25198–203. doi: 10.1074/jbc.271.41.25198 . PMID   8810278.
22. Mayer BJ, Hirai H, Sakai R (March 1995). "Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases". Curr. Biol. 5 (3): 296–305. Bibcode:1995CBio....5..296M. doi: 10.1016/S0960-9822(95)00060-1 . PMID   7780740. S2CID   16957239.
23. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T (February 1994). "Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway". EMBO J. 13 (4): 764–73. doi:10.1002/j.1460-2075.1994.tb06319.x. PMC   394874 . PMID   8112292.
24. Ling X, Ma G, Sun T, Liu J, Arlinghaus RB (January 2003). "Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr". Cancer Res. 63 (2): 298–303. PMID   12543778.
25. Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON (July 1991). "BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner". Cell. 66 (1): 161–71. doi:10.1016/0092-8674(91)90148-R. PMID   1712671. S2CID   9933891.
26. Foray N, Marot D, Randrianarison V, Venezia ND, Picard D, Perricaudet M, Favaudon V, Jeggo P (June 2002). "Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation". Mol. Cell. Biol. 22 (12): 4020–32. doi:10.1128/MCB.22.12.4020-4032.2002. PMC   133860 . PMID   12024016.
27. Cao C, Leng Y, Kufe D (August 2003). "Catalase activity is regulated by c-Abl and Arg in the oxidative stress response". J. Biol. Chem. 278 (32): 29667–75. doi: 10.1074/jbc.M301292200 . PMID   12777400.
28. Miyoshi-Akiyama T, Aleman LM, Smith JM, Adler CE, Mayer BJ (July 2001). "Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor". Oncogene. 20 (30): 4058–69. doi: 10.1038/sj.onc.1204528 . PMID   11494134.
29. Soubeyran P, Barac A, Szymkiewicz I, Dikic I (February 2003). "Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl". Biochem. J. 370 (Pt 1): 29–34. doi:10.1042/BJ20021539. PMC   1223168 . PMID   12475393.
30. Ren R, Ye ZS, Baltimore D (April 1994). "Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites". Genes Dev. 8 (7): 783–95. doi: 10.1101/gad.8.7.783 . PMID   7926767.
31. Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker BJ (January 1997). "Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation". Blood. 89 (1): 297–306. doi: 10.1182/blood.V89.1.297 . PMID   8978305.
32. Kyono WT, de Jong R, Park RK, Liu Y, Heisterkamp N, Groffen J, Durden DL (November 1998). "Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI)". J. Immunol. 161 (10): 5555–63. doi: 10.4049/jimmunol.161.10.5555 . PMID   9820532.
33. van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Löwenberg B, von Lindern M (November 2000). "Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells". Blood. 96 (10): 3406–13. doi:10.1182/blood.V96.10.3406. hdl: 1765/9530 . PMID   11071635.
34. Yamanashi Y, Baltimore D (January 1997). "Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok". Cell. 88 (2): 205–11. doi: 10.1016/S0092-8674(00)81841-3 . PMID   9008161. S2CID   14205526.
35. Yu HH, Zisch AH, Dodelet VC, Pasquale EB (July 2001). "Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor". Oncogene. 20 (30): 3995–4006. doi:10.1038/sj.onc.1204524. PMID   11494128. S2CID   25752193.
36. Cao C, Leng Y, Huang W, Liu X, Kufe D (October 2003). "Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases". J. Biol. Chem. 278 (41): 39609–14. doi: 10.1074/jbc.M305770200 . PMID   12893824.
37. Bai RY, Jahn T, Schrem S, Munzert G, Weidner KM, Wang JY, Duyster J (August 1998). "The SH2-containing adapter protein GRB10 interacts with BCR-ABL". Oncogene. 17 (8): 941–8. doi:10.1038/sj.onc.1202024. PMID   9747873. S2CID   20866214.
38. Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE (January 1997). "Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains". J. Biol. Chem. 272 (5): 2659–67. doi: 10.1074/jbc.272.5.2659 . PMID   9006901.
39. Kumar V, Sabatini D, Pandey P, Gingras AC, Majumder PK, Kumar M, Yuan ZM, Carmichael G, Weichselbaum R, Sonenberg N, Kufe D, Kharbanda S (April 2000). "Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase". J. Biol. Chem. 275 (15): 10779–87. doi: 10.1074/jbc.275.15.10779 . PMID   10753870.
40. Warmuth M, Bergmann M, Priess A, Häuslmann K, Emmerich B, Hallek M (December 1997). "The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr". J. Biol. Chem. 272 (52): 33260–70. doi: 10.1074/jbc.272.52.33260 . PMID   9407116.
41. Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van Etten RA, Oren M, Taya Y, Haupt Y (July 2002). "Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation". EMBO J. 21 (14): 3715–27. doi:10.1093/emboj/cdf384. PMC   125401 . PMID   12110584.
42. Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, Morimoto C (October 1996). "Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes". J. Exp. Med. 184 (4): 1365–75. doi:10.1084/jem.184.4.1365. PMC   2192828 . PMID   8879209.
43. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh G, Golemis EA (July 1996). "Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae". Mol. Cell. Biol. 16 (7): 3327–37. doi:10.1128/mcb.16.7.3327. PMC   231327 . PMID   8668148.
44. Koch A, Mancini A, Stefan M, Niedenthal R, Niemann H, Tamura T (March 2000). "Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop". FEBS Lett. 469 (1): 72–6. doi: 10.1016/S0014-5793(00)01242-4 . PMID   10708759.
45. Yano H, Cong F, Birge RB, Goff SP, Chao MV (February 2000). "Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor". J. Neurosci. Res. 59 (3): 356–64. doi:10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G. PMID   10679771. S2CID   10977765.
46. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D (June 1999). "p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage". Nature. 399 (6738): 814–7. Bibcode:1999Natur.399..814Y. doi:10.1038/21704. PMID   10391251. S2CID   4421613.
47. Agami R, Blandino G, Oren M, Shaul Y (June 1999). "Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis". Nature. 399 (6738): 809–13. Bibcode:1999Natur.399..809A. doi:10.1038/21697. PMID   10391250. S2CID   4394015.
48. Wen ST, Van Etten RA (October 1997). "The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity". Genes Dev. 11 (19): 2456–67. doi:10.1101/gad.11.19.2456. PMC   316562 . PMID   9334312.
49. Roig J, Tuazon PT, Zipfel PA, Pendergast AM, Traugh JA (December 2000). "Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK". Proc. Natl. Acad. Sci. U.S.A. 97 (26): 14346–51. Bibcode:2000PNAS...9714346R. doi: 10.1073/pnas.97.26.14346 . PMC   18921 . PMID   11121037.
50. Cong F, Spencer S, Côté JF, Wu Y, Tremblay ML, Lasky LA, Goff SP (December 2000). "Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation". Mol. Cell. 6 (6): 1413–23. doi: 10.1016/S1097-2765(00)00138-6 . PMID   11163214.
51. Yoshida K, Komatsu K, Wang HG, Kufe D (May 2002). "c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage". Mol. Cell. Biol. 22 (10): 3292–300. doi:10.1128/MCB.22.10.3292-3300.2002. PMC   133797 . PMID   11971963.
52. Miyamura T, Nishimura J, Yufu Y, Nawata H (February 1997). "Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines". Int. J. Hematol. 65 (2): 115–21. doi:10.1016/S0925-5710(96)00539-7. PMID   9071815.
53. Welch PJ, Wang JY (November 1993). "A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle". Cell. 75 (4): 779–90. doi: 10.1016/0092-8674(93)90497-E . PMID   8242749.
54. Agami R, Shaul Y (April 1998). "The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes". Oncogene. 16 (14): 1779–88. doi: 10.1038/sj.onc.1201708 . PMID   9583676.
55. Zhu J, Shore SK (December 1996). "c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein". Mol. Cell. Biol. 16 (12): 7054–62. doi:10.1128/mcb.16.12.7054. PMC   231708 . PMID   8943360.
56. Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, Geromanos S, Kavanaugh WM, Tempst P, Clarkson B (April 1999). "A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells". Blood. 93 (8): 2707–20. doi:10.1182/blood.V93.8.2707. PMID   10194451.
57. Wang B, Golemis EA, Kruh GD (July 1997). "ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks". J. Biol. Chem. 272 (28): 17542–50. doi: 10.1074/jbc.272.28.17542 . hdl: 20.500.12613/9174 . PMID   9211900.
58. Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim KS, Jenkins EC, Trenkner E, Kotula L (May 1998). "Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton". J. Biol. Chem. 273 (22): 13681–92. doi: 10.1074/jbc.273.22.13681 . PMID   9593709.
59. Bassermann F, Jahn T, Miething C, Seipel P, Bai RY, Coutinho S, Tybulewicz VL, Peschel C, Duyster J (April 2002). "Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway". J. Biol. Chem. 277 (14): 12437–45. doi: 10.1074/jbc.M112397200 . PMID   11790798.
60. Rafalska I, Zhang Z, Benderska N, Wolff H, Hartmann AM, Brack-Werner R, Stamm S (August 2004). "The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation". Hum. Mol. Genet. 13 (15): 1535–49. doi:10.1093/hmg/ddh167. PMID   15175272.
61. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M (June 2008). "Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression". Cancer Cell. 13 (6): 496–506. doi:10.1016/j.ccr.2008.04.018. hdl: 10261/7369 . PMID   18538733. (Erratum:  doi:10.1016/j.ccell.2016.03.013, PMID   27070707)

Further reading

• Shore SK, Tantravahi RV, Reddy EP (December 2002). "Transforming pathways activated by the v-Abl tyrosine kinase". Oncogene. 21 (56): 8568–76. doi:10.1038/sj.onc.1206084. PMID   12476303. S2CID   42502628.
• Shaul Y (2000). "c-Abl: activation and nuclear targets". Cell Death Differ. 7 (1): 10–6. doi: 10.1038/sj.cdd.4400626 . PMID   10713716.
• Era T (2002). "Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells". Int. J. Hematol. 76 (1): 35–43. doi:10.1007/BF02982716. PMID   12138893. S2CID   10269867.
• Pendergast AM (2002). "The Abl family kinases: mechanisms of regulation and signaling". Advances in Cancer Research Volume 85. Vol. 85. pp. 51–100. doi:10.1016/S0065-230X(02)85003-5. ISBN   978-0-12-006685-8. PMID   12374288.{{cite book}}: |journal= ignored (help)
• Keung YK, Beaty M, Steward W, Jackle B, Pettnati M (2002). "Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature". Cancer Genet. Cytogenet. 138 (2): 139–42. doi:10.1016/S0165-4608(02)00609-X. PMID   12505259.
• Saglio G, Cilloni D (2004). "Abl: the prototype of oncogenic fusion proteins". Cell. Mol. Life Sci. 61 (23): 2897–911. doi:10.1007/s00018-004-4271-0. PMID   15583852. S2CID   35998018.
• Shaul Y, Ben-Yehoyada M (2005). "Role of c-Abl in the DNA damage stress response". Cell Res. 15 (1): 33–5. doi: 10.1038/sj.cr.7290261 . PMID   15686624.
• Yoshida K (2007). "Regulation for Nuclear Targeting of the Abl Tyrosine Kinase in Response to DNA Damage" . Advances in Molecular Oncology. Advances in Experimental Medicine and Biology. Vol. 604. Springer. pp.  155–65. doi:10.1007/978-0-387-69116-9_15. ISBN   978-0-387-69114-5. PMID   17695727.

External links

• Genes,+abl at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• Online Mendelian Inheritance in Man (OMIM): 189980 (ABL)
• Abelson+Leukemia+Virus at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• DrosophilaAbl tyrosine kinase - The Interactive Fly
• ABL1 Info with links in the Cell Migration Gateway
• ABL1 on the Atlas of Genetics and Oncology
• Human ABL1 genome location and ABL1 gene details page in the UCSC Genome Browser .
• Overview of all the structural information available in the PDB for UniProt : P00519 (Human Tyrosine-protein kinase ABL1) at the PDBe-KB .
• Overview of all the structural information available in the PDB for UniProt : P00520 (Mouse Tyrosine-protein kinase ABL1) at the PDBe-KB .